| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.22e-11 | 29 | 37 | 6 | GO:0035325 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 3.26e-11 | 14 | 37 | 5 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 5.42e-10 | 23 | 37 | 5 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 1.90e-09 | 29 | 37 | 5 | GO:0031005 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 4.41e-09 | 34 | 37 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.47e-08 | 90 | 37 | 6 | GO:0008028 | |
| GeneOntologyMolecularFunction | glycolipid binding | 2.96e-08 | 49 | 37 | 5 | GO:0051861 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 9.19e-08 | 207 | 37 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 9.50e-08 | 208 | 37 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.83e-07 | 70 | 37 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.26e-07 | 73 | 37 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 3.00e-07 | 149 | 37 | 6 | GO:1990782 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 9.63e-07 | 293 | 37 | 7 | GO:0008514 | |
| GeneOntologyMolecularFunction | actin binding | 2.17e-06 | 479 | 37 | 8 | GO:0003779 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 2.23e-06 | 210 | 37 | 6 | GO:0019903 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.77e-06 | 230 | 37 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | phosphatase binding | 8.32e-06 | 264 | 37 | 6 | GO:0019902 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 1.60e-05 | 173 | 37 | 5 | GO:0070851 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.92e-05 | 196 | 37 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | frizzled binding | 6.40e-05 | 42 | 37 | 3 | GO:0005109 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 8.32e-05 | 398 | 37 | 6 | GO:0046982 | |
| GeneOntologyMolecularFunction | protein kinase binding | 1.61e-04 | 873 | 37 | 8 | GO:0019901 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 2.77e-04 | 316 | 37 | 5 | GO:0035091 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 3.10e-04 | 324 | 37 | 5 | GO:0005126 | |
| GeneOntologyMolecularFunction | kinase binding | 3.28e-04 | 969 | 37 | 8 | GO:0019900 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 6.48e-04 | 815 | 37 | 7 | GO:0042803 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 7.59e-04 | 1099 | 37 | 8 | GO:0008092 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.21e-03 | 1180 | 37 | 8 | GO:0022857 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 1.38e-03 | 1205 | 37 | 8 | GO:0046983 | |
| GeneOntologyMolecularFunction | ribosome binding | 1.42e-03 | 120 | 37 | 3 | GO:0043022 | |
| GeneOntologyMolecularFunction | transporter activity | 2.12e-03 | 1289 | 37 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | small GTPase binding | 2.85e-03 | 321 | 37 | 4 | GO:0031267 | |
| GeneOntologyMolecularFunction | phospholipid binding | 3.22e-03 | 548 | 37 | 5 | GO:0005543 | |
| GeneOntologyMolecularFunction | GTPase binding | 4.29e-03 | 360 | 37 | 4 | GO:0051020 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 6.50e-03 | 206 | 37 | 3 | GO:0043021 | |
| GeneOntologyMolecularFunction | lipid binding | 9.02e-03 | 988 | 37 | 6 | GO:0008289 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 2.77e-11 | 14 | 37 | 5 | GO:0070348 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 4.16e-11 | 15 | 37 | 5 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 4.16e-11 | 15 | 37 | 5 | GO:0002859 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 4.16e-11 | 15 | 37 | 5 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 4.16e-11 | 15 | 37 | 5 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 6.04e-11 | 16 | 37 | 5 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 8.54e-11 | 17 | 37 | 5 | GO:0070342 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 8.54e-11 | 17 | 37 | 5 | GO:0038158 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 8.54e-11 | 17 | 37 | 5 | GO:1901143 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.18e-10 | 18 | 37 | 5 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 2.13e-10 | 20 | 37 | 5 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 2.22e-10 | 47 | 37 | 6 | GO:0034104 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 2.79e-10 | 21 | 37 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 2.79e-10 | 21 | 37 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 2.79e-10 | 21 | 37 | 5 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 3.34e-10 | 159 | 37 | 8 | GO:1903707 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 3.61e-10 | 22 | 37 | 5 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 4.61e-10 | 23 | 37 | 5 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 4.61e-10 | 23 | 37 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 5.81e-10 | 24 | 37 | 5 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 5.81e-10 | 24 | 37 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 5.81e-10 | 24 | 37 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 7.26e-10 | 25 | 37 | 5 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 7.26e-10 | 25 | 37 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.10e-09 | 27 | 37 | 5 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.34e-09 | 28 | 37 | 5 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.61e-09 | 29 | 37 | 5 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 2.30e-09 | 31 | 37 | 5 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 2.73e-09 | 32 | 37 | 5 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 2.73e-09 | 32 | 37 | 5 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 2.73e-09 | 32 | 37 | 5 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 3.21e-09 | 33 | 37 | 5 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 3.21e-09 | 33 | 37 | 5 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 3.76e-09 | 34 | 37 | 5 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 3.76e-09 | 34 | 37 | 5 | GO:0046851 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 4.38e-09 | 35 | 37 | 5 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 6.74e-09 | 38 | 37 | 5 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 7.72e-09 | 39 | 37 | 5 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 8.39e-09 | 151 | 37 | 7 | GO:1902106 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | 8.63e-09 | 240 | 37 | 8 | GO:0002695 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 8.82e-09 | 40 | 37 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.00e-08 | 41 | 37 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.14e-08 | 42 | 37 | 5 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 1.62e-08 | 166 | 37 | 7 | GO:0002698 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.63e-08 | 45 | 37 | 5 | GO:0048521 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.80e-08 | 96 | 37 | 6 | GO:0002704 | |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | 1.81e-08 | 264 | 37 | 8 | GO:0050866 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.82e-08 | 46 | 37 | 5 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.82e-08 | 46 | 37 | 5 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 1.99e-08 | 171 | 37 | 7 | GO:0050868 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 2.04e-08 | 47 | 37 | 5 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 2.04e-08 | 47 | 37 | 5 | GO:0001911 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 2.53e-08 | 49 | 37 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 2.53e-08 | 49 | 37 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 2.80e-08 | 50 | 37 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 3.43e-08 | 52 | 37 | 5 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 3.45e-08 | 107 | 37 | 6 | GO:0042130 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 3.78e-08 | 53 | 37 | 5 | GO:0034110 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte cell-cell adhesion | 4.41e-08 | 192 | 37 | 7 | GO:1903038 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 5.01e-08 | 56 | 37 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 6.54e-08 | 59 | 37 | 5 | GO:0045671 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 7.13e-08 | 60 | 37 | 5 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 7.13e-08 | 60 | 37 | 5 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 7.76e-08 | 61 | 37 | 5 | GO:0060259 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 8.34e-08 | 124 | 37 | 6 | GO:0050672 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | 8.42e-08 | 211 | 37 | 7 | GO:0051250 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 9.18e-08 | 126 | 37 | 6 | GO:0032945 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 1.01e-07 | 128 | 37 | 6 | GO:0034103 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 1.06e-07 | 129 | 37 | 6 | GO:0043406 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.16e-07 | 66 | 37 | 5 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 1.25e-07 | 67 | 37 | 5 | GO:0045601 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 1.32e-07 | 134 | 37 | 6 | GO:0070664 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.45e-07 | 69 | 37 | 5 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 1.56e-07 | 70 | 37 | 5 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 1.56e-07 | 70 | 37 | 5 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 1.68e-07 | 71 | 37 | 5 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.68e-07 | 71 | 37 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 1.70e-07 | 353 | 37 | 8 | GO:0010721 | |
| GeneOntologyBiologicalProcess | negative regulation of defense response | 1.70e-07 | 353 | 37 | 8 | GO:0031348 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 1.80e-07 | 72 | 37 | 5 | GO:0032692 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 1.80e-07 | 72 | 37 | 5 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 1.93e-07 | 73 | 37 | 5 | GO:0042304 | |
| GeneOntologyBiologicalProcess | negative regulation of response to external stimulus | 2.13e-07 | 509 | 37 | 9 | GO:0032102 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 2.36e-07 | 76 | 37 | 5 | GO:0042269 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 2.39e-07 | 246 | 37 | 7 | GO:0045216 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 2.69e-07 | 151 | 37 | 6 | GO:0002832 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | 2.82e-07 | 252 | 37 | 7 | GO:0022408 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection arborization | 2.96e-07 | 8 | 37 | 3 | GO:0150012 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 3.06e-07 | 80 | 37 | 5 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 3.06e-07 | 80 | 37 | 5 | GO:0002715 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 3.68e-07 | 83 | 37 | 5 | GO:0002707 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 4.15e-07 | 85 | 37 | 5 | GO:1903670 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 4.15e-07 | 85 | 37 | 5 | GO:0002762 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 4.40e-07 | 86 | 37 | 5 | GO:0042058 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 4.66e-07 | 87 | 37 | 5 | GO:0001974 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 5.83e-07 | 91 | 37 | 5 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 5.83e-07 | 91 | 37 | 5 | GO:0030193 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 6.50e-07 | 93 | 37 | 5 | GO:1900046 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 6.50e-07 | 93 | 37 | 5 | GO:1901184 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 7.23e-07 | 95 | 37 | 5 | GO:0070527 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 5.65e-11 | 16 | 37 | 5 | GO:0070021 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 2.00e-10 | 90 | 37 | 7 | GO:0016328 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 3.13e-07 | 157 | 37 | 6 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 5.00e-07 | 170 | 37 | 6 | GO:1902911 | |
| GeneOntologyCellularComponent | apical part of cell | 6.75e-07 | 592 | 37 | 9 | GO:0045177 | |
| GeneOntologyCellularComponent | ciliary membrane | 7.91e-07 | 98 | 37 | 5 | GO:0060170 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.28e-06 | 320 | 37 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | adherens junction | 1.81e-06 | 212 | 37 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | basal plasma membrane | 2.50e-06 | 354 | 37 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 3.86e-06 | 378 | 37 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | cell projection membrane | 9.10e-06 | 431 | 37 | 7 | GO:0031253 | |
| GeneOntologyCellularComponent | T cell receptor complex | 9.66e-06 | 163 | 37 | 5 | GO:0042101 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.00e-05 | 487 | 37 | 7 | GO:0016324 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 2.48e-05 | 335 | 37 | 6 | GO:0061695 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 3.17e-05 | 350 | 37 | 6 | GO:0098802 | |
| GeneOntologyCellularComponent | Wnt signalosome | 3.60e-04 | 16 | 37 | 2 | GO:1990909 | |
| GeneOntologyCellularComponent | receptor complex | 5.01e-04 | 581 | 37 | 6 | GO:0043235 | |
| GeneOntologyCellularComponent | cell-cell junction | 5.49e-04 | 591 | 37 | 6 | GO:0005911 | |
| GeneOntologyCellularComponent | transferase complex | 1.32e-03 | 963 | 37 | 7 | GO:1990234 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 2.09e-03 | 519 | 37 | 5 | GO:0009897 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 2.36e-03 | 785 | 37 | 6 | GO:0098797 | |
| GeneOntologyCellularComponent | cell surface | 2.98e-03 | 1111 | 37 | 7 | GO:0009986 | |
| GeneOntologyCellularComponent | side of membrane | 4.05e-03 | 875 | 37 | 6 | GO:0098552 | |
| GeneOntologyCellularComponent | cilium | 4.59e-03 | 898 | 37 | 6 | GO:0005929 | |
| GeneOntologyCellularComponent | anchoring junction | 6.86e-03 | 976 | 37 | 6 | GO:0070161 | |
| HumanPheno | Abnormal labia minora morphology | 9.52e-06 | 41 | 6 | 3 | HP:0012880 | |
| HumanPheno | Naevus flammeus of the eyelid | 2.42e-05 | 7 | 6 | 2 | HP:0010733 | |
| HumanPheno | Euryblepharon | 4.15e-05 | 9 | 6 | 2 | HP:0012905 | |
| HumanPheno | Ridged fingernail | 4.15e-05 | 9 | 6 | 2 | HP:0008402 | |
| HumanPheno | Onychogryposis of fingernail | 4.15e-05 | 9 | 6 | 2 | HP:0040036 | |
| HumanPheno | Abnormal labia morphology | 9.60e-05 | 88 | 6 | 3 | HP:0000058 | |
| HumanPheno | Curly eyelashes | 1.21e-04 | 15 | 6 | 2 | HP:0007665 | |
| HumanPheno | Fingernail dysplasia | 1.38e-04 | 16 | 6 | 2 | HP:0100798 | |
| HumanPheno | Abnormal clitoris morphology | 1.41e-04 | 100 | 6 | 3 | HP:0000056 | |
| HumanPheno | Anodontia | 1.96e-04 | 19 | 6 | 2 | HP:0000674 | |
| HumanPheno | Femoral hernia | 2.18e-04 | 20 | 6 | 2 | HP:0100541 | |
| HumanPheno | Triangular mouth | 2.18e-04 | 20 | 6 | 2 | HP:0000207 | |
| HumanPheno | Skin dimple | 2.42e-04 | 120 | 6 | 3 | HP:0010781 | |
| HumanPheno | Bifid tongue | 3.43e-04 | 25 | 6 | 2 | HP:0010297 | |
| HumanPheno | Epispadias | 4.63e-04 | 29 | 6 | 2 | HP:0000039 | |
| HumanPheno | Onychogryposis | 4.63e-04 | 29 | 6 | 2 | HP:0001805 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 4.96e-04 | 30 | 6 | 2 | HP:0005743 | |
| HumanPheno | Abnormal female external genitalia morphology | 5.78e-04 | 161 | 6 | 3 | HP:0000055 | |
| HumanPheno | Clitoral hypoplasia | 6.38e-04 | 34 | 6 | 2 | HP:0000060 | |
| HumanPheno | Aplasia/Hypoplasia of the clitoris | 6.38e-04 | 34 | 6 | 2 | HP:0040255 | |
| HumanPheno | Ridged nail | 6.38e-04 | 34 | 6 | 2 | HP:0001807 | |
| HumanPheno | Hypoplastic labia minora | 6.76e-04 | 35 | 6 | 2 | HP:0000064 | |
| HumanPheno | Mesomelia | 6.76e-04 | 35 | 6 | 2 | HP:0003027 | |
| HumanPheno | Hypoplastic labia majora | 7.56e-04 | 37 | 6 | 2 | HP:0000059 | |
| HumanPheno | Capillary hemangioma | 8.40e-04 | 39 | 6 | 2 | HP:0005306 | |
| HumanPheno | Abnormal nail surface | 8.84e-04 | 40 | 6 | 2 | HP:0025757 | |
| HumanPheno | Juvenile aseptic necrosis | 1.02e-03 | 43 | 6 | 2 | HP:0100323 | |
| HumanPheno | Abnormal labia majora morphology | 1.12e-03 | 45 | 6 | 2 | HP:0012881 | |
| HumanPheno | Median cleft palate | 1.73e-03 | 56 | 6 | 2 | HP:0009099 | |
| HumanPheno | Median cleft upper lip | 1.73e-03 | 56 | 6 | 2 | HP:0000161 | |
| HumanPheno | Median cleft lip and palate | 1.73e-03 | 56 | 6 | 2 | HP:0008501 | |
| HumanPheno | Nevus flammeus | 1.79e-03 | 57 | 6 | 2 | HP:0001052 | |
| HumanPheno | Open bite | 2.05e-03 | 61 | 6 | 2 | HP:0010807 | |
| HumanPheno | Hemivertebrae | 2.12e-03 | 62 | 6 | 2 | HP:0002937 | |
| HumanPheno | Labial hypoplasia | 2.26e-03 | 64 | 6 | 2 | HP:0000066 | |
| HumanPheno | Oligodontia | 2.33e-03 | 65 | 6 | 2 | HP:0000677 | |
| HumanPheno | Prominent forehead | 2.37e-03 | 261 | 6 | 3 | HP:0011220 | |
| HumanPheno | Capillary malformation | 2.47e-03 | 67 | 6 | 2 | HP:0025104 | |
| HumanPheno | Coxa vara | 2.54e-03 | 68 | 6 | 2 | HP:0002812 | |
| HumanPheno | Hypoplastic female external genitalia | 2.54e-03 | 68 | 6 | 2 | HP:0012815 | |
| HumanPheno | Long palpebral fissure | 2.77e-03 | 71 | 6 | 2 | HP:0000637 | |
| HumanPheno | Abnormal epiphysis morphology | 2.87e-03 | 279 | 6 | 3 | HP:0005930 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 8.65e-13 | 17 | 31 | 6 | MP:0031047 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 2.59e-11 | 28 | 31 | 6 | MP:0020950 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 4.74e-10 | 44 | 31 | 6 | MP:0031023 | |
| MousePheno | increased skeletal muscle triglyceride level | 7.59e-10 | 21 | 31 | 5 | MP:0031415 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 9.31e-10 | 49 | 31 | 6 | MP:0020948 | |
| MousePheno | decreased fatty acid oxidation | 1.58e-09 | 24 | 31 | 5 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 2.98e-09 | 27 | 31 | 5 | MP:0009286 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 3.28e-09 | 60 | 31 | 6 | MP:0009790 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 6.24e-09 | 31 | 31 | 5 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 6.24e-09 | 31 | 31 | 5 | MP:0008964 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.18e-08 | 35 | 31 | 5 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 1.37e-08 | 36 | 31 | 5 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 2.09e-08 | 39 | 31 | 5 | MP:0030022 | |
| MousePheno | decreased susceptibility to Riboviria infection | 2.22e-08 | 82 | 31 | 6 | MP:0020914 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 5.49e-08 | 47 | 31 | 5 | MP:0031617 | |
| MousePheno | decreased cellular glucose uptake | 1.02e-07 | 53 | 31 | 5 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 1.12e-07 | 54 | 31 | 5 | MP:0010953 | |
| MousePheno | abnormal lipid oxidation | 2.08e-07 | 61 | 31 | 5 | MP:0010951 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 2.18e-07 | 120 | 31 | 6 | MP:0009786 | |
| MousePheno | increased insulin secretion | 2.66e-07 | 64 | 31 | 5 | MP:0003058 | |
| MousePheno | decreased susceptibility to viral infection | 2.78e-07 | 125 | 31 | 6 | MP:0002410 | |
| MousePheno | abnormal muscle cell glucose uptake | 3.35e-07 | 67 | 31 | 5 | MP:0004130 | |
| MousePheno | abnormal carbon dioxide production | 3.35e-07 | 67 | 31 | 5 | MP:0008962 | |
| MousePheno | abnormal vascular wound healing | 5.17e-07 | 73 | 31 | 5 | MP:0004883 | |
| MousePheno | decreased oxygen consumption | 7.68e-07 | 79 | 31 | 5 | MP:0005290 | |
| MousePheno | polyphagia | 8.18e-07 | 80 | 31 | 5 | MP:0001433 | |
| MousePheno | abnormal colon morphology | 8.81e-07 | 152 | 31 | 6 | MP:0000495 | |
| MousePheno | abnormal cellular glucose uptake | 2.74e-06 | 102 | 31 | 5 | MP:0003925 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 2.86e-06 | 186 | 31 | 6 | MP:0020912 | |
| MousePheno | decreased respiratory quotient | 3.97e-06 | 110 | 31 | 5 | MP:0010379 | |
| MousePheno | obese | 4.54e-06 | 113 | 31 | 5 | MP:0001261 | |
| MousePheno | decreased energy expenditure | 5.85e-06 | 119 | 31 | 5 | MP:0004890 | |
| MousePheno | increased circulating leptin level | 7.44e-06 | 125 | 31 | 5 | MP:0005669 | |
| MousePheno | increased incidence of tumors by chemical induction | 1.34e-05 | 141 | 31 | 5 | MP:0004499 | |
| MousePheno | abnormal glycogen homeostasis | 1.48e-05 | 144 | 31 | 5 | MP:0005438 | |
| MousePheno | decreased susceptibility to infection | 1.74e-05 | 255 | 31 | 6 | MP:0002409 | |
| MousePheno | abnormal blood vessel physiology | 1.96e-05 | 394 | 31 | 7 | MP:0000249 | |
| MousePheno | abnormal vasculature physiology | 2.31e-05 | 404 | 31 | 7 | MP:0031170 | |
| MousePheno | abnormal incidence of induced tumors | 2.36e-05 | 269 | 31 | 6 | MP:0013151 | |
| MousePheno | abnormal large intestine morphology | 2.73e-05 | 276 | 31 | 6 | MP:0000489 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 2.90e-05 | 279 | 31 | 6 | MP:0009785 | |
| MousePheno | abnormal susceptibility to viral infection | 2.90e-05 | 279 | 31 | 6 | MP:0020185 | |
| MousePheno | abnormal insulin secretion | 3.39e-05 | 171 | 31 | 5 | MP:0003564 | |
| MousePheno | increased incidence of induced tumors | 3.59e-05 | 173 | 31 | 5 | MP:0002021 | |
| MousePheno | abnormal endocrine pancreas secretion | 3.89e-05 | 176 | 31 | 5 | MP:0014195 | |
| MousePheno | abnormal respiratory quotient | 4.11e-05 | 178 | 31 | 5 | MP:0004129 | |
| MousePheno | abnormal pancreas secretion | 4.69e-05 | 183 | 31 | 5 | MP:0002694 | |
| MousePheno | increased food intake | 5.47e-05 | 189 | 31 | 5 | MP:0011939 | |
| MousePheno | abnormal wound healing | 6.04e-05 | 193 | 31 | 5 | MP:0005023 | |
| MousePheno | abnormal oxygen consumption | 6.35e-05 | 195 | 31 | 5 | MP:0005288 | |
| MousePheno | abnormal pancreatic beta cell physiology | 6.50e-05 | 196 | 31 | 5 | MP:0003562 | |
| MousePheno | insulin resistance | 6.66e-05 | 197 | 31 | 5 | MP:0005331 | |
| MousePheno | abnormal endocrine pancreas physiology | 7.50e-05 | 202 | 31 | 5 | MP:0010147 | |
| MousePheno | abnormal susceptibility to infection | 8.06e-05 | 672 | 31 | 8 | MP:0001793 | |
| MousePheno | abnormal response to infection | 1.23e-04 | 714 | 31 | 8 | MP:0005025 | |
| MousePheno | abnormal response to antigen | 1.38e-04 | 726 | 31 | 8 | MP:0020000 | |
| MousePheno | abnormal intestine morphology | 1.55e-04 | 546 | 31 | 7 | MP:0000477 | |
| MousePheno | abnormal circulating leptin level | 1.56e-04 | 236 | 31 | 5 | MP:0005667 | |
| MousePheno | abnormal abdominal fat pad morphology | 2.54e-04 | 262 | 31 | 5 | MP:0000010 | |
| MousePheno | abnormal gas homeostasis | 2.77e-04 | 600 | 31 | 7 | MP:0003948 | |
| MousePheno | increased total body fat amount | 2.90e-04 | 424 | 31 | 6 | MP:0010024 | |
| MousePheno | decreased circulating triglyceride level | 3.17e-04 | 275 | 31 | 5 | MP:0002644 | |
| MousePheno | increased circulating insulin level | 3.62e-04 | 283 | 31 | 5 | MP:0002079 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 3.80e-04 | 286 | 31 | 5 | MP:0008873 | |
| MousePheno | abnormal pancreas physiology | 4.18e-04 | 292 | 31 | 5 | MP:0002693 | |
| MousePheno | abnormal energy expenditure | 5.74e-04 | 313 | 31 | 5 | MP:0005450 | |
| MousePheno | abnormal fat pad morphology | 5.82e-04 | 314 | 31 | 5 | MP:0005334 | |
| MousePheno | abnormal energy homeostasis | 6.53e-04 | 322 | 31 | 5 | MP:0005448 | |
| MousePheno | abnormal skeletal muscle morphology | 7.59e-04 | 508 | 31 | 6 | MP:0000759 | |
| MousePheno | decreased triglyceride level | 9.26e-04 | 348 | 31 | 5 | MP:0005318 | |
| MousePheno | increased triglyceride level | 1.00e-03 | 354 | 31 | 5 | MP:0005317 | |
| MousePheno | increased lean body mass | 1.00e-03 | 354 | 31 | 5 | MP:0003960 | |
| MousePheno | abnormal endocrine gland physiology | 1.12e-03 | 363 | 31 | 5 | MP:0013561 | |
| MousePheno | increased total tissue mass | 1.13e-03 | 364 | 31 | 5 | MP:0012323 | |
| MousePheno | increased body weight | 1.13e-03 | 364 | 31 | 5 | MP:0001260 | |
| MousePheno | increased circulating hormone level | 1.48e-03 | 578 | 31 | 6 | MP:0014456 | |
| MousePheno | increased body size | 1.90e-03 | 409 | 31 | 5 | MP:0001264 | |
| MousePheno | abnormal response to injury | 1.90e-03 | 607 | 31 | 6 | MP:0005164 | |
| MousePheno | abnormal tumor incidence | 2.39e-03 | 635 | 31 | 6 | MP:0002019 | |
| MousePheno | increased hormone level | 2.50e-03 | 641 | 31 | 6 | MP:0014454 | |
| MousePheno | abnormal tumor susceptibility | 2.69e-03 | 650 | 31 | 6 | MP:0002166 | |
| MousePheno | abnormal physiological response to xenobiotic | 2.94e-03 | 662 | 31 | 6 | MP:0008872 | |
| MousePheno | impaired glucose tolerance | 3.79e-03 | 480 | 31 | 5 | MP:0005293 | |
| MousePheno | abnormal food intake | 3.83e-03 | 481 | 31 | 5 | MP:0005449 | |
| MousePheno | abnormal muscle physiology | 4.17e-03 | 954 | 31 | 7 | MP:0002106 | |
| MousePheno | abnormal xiphoid process morphology | 4.44e-03 | 45 | 31 | 2 | MP:0000159 | |
| MousePheno | decreased lipid level | 4.67e-03 | 727 | 31 | 6 | MP:0014461 | |
| MousePheno | abnormal circulating insulin level | 4.71e-03 | 505 | 31 | 5 | MP:0001560 | |
| MousePheno | abnormal induced morbidity/mortality | 4.99e-03 | 737 | 31 | 6 | MP:0001657 | |
| MousePheno | abnormal circulating triglyceride level | 5.16e-03 | 516 | 31 | 5 | MP:0011969 | |
| Domain | Dishevelled | 1.46e-11 | 4 | 38 | 4 | PF02377 | |
| Domain | Dishevelled_protein_dom | 1.46e-11 | 4 | 38 | 4 | IPR003351 | |
| Domain | Dishevelled_fam | 1.46e-11 | 4 | 38 | 4 | IPR008339 | |
| Domain | DIX | 5.07e-10 | 7 | 38 | 4 | IPR001158 | |
| Domain | DIX | 5.07e-10 | 7 | 38 | 4 | PS50841 | |
| Domain | DAX | 5.07e-10 | 7 | 38 | 4 | SM00021 | |
| Domain | DIX | 5.07e-10 | 7 | 38 | 4 | PF00778 | |
| Domain | Ig_2 | 7.23e-09 | 73 | 38 | 6 | PF13895 | |
| Domain | Dsh_C | 7.77e-09 | 3 | 38 | 3 | PF12316 | |
| Domain | Dishevelled_C-dom | 7.77e-09 | 3 | 38 | 3 | IPR024580 | |
| Domain | Dsh/Dvl-rel | 3.10e-08 | 4 | 38 | 3 | IPR015506 | |
| Domain | DEP | 1.04e-07 | 22 | 38 | 4 | PF00610 | |
| Domain | DEP | 1.04e-07 | 22 | 38 | 4 | SM00049 | |
| Domain | DEP | 1.04e-07 | 22 | 38 | 4 | PS50186 | |
| Domain | DEP_dom | 1.25e-07 | 23 | 38 | 4 | IPR000591 | |
| Domain | V-set | 1.79e-06 | 184 | 38 | 6 | PF07686 | |
| Domain | ig | 2.16e-06 | 190 | 38 | 6 | PF00047 | |
| Domain | Immunoglobulin | 2.16e-06 | 190 | 38 | 6 | IPR013151 | |
| Domain | Ig_V-set | 2.82e-06 | 199 | 38 | 6 | IPR013106 | |
| Domain | DVL-1 | 4.03e-06 | 2 | 38 | 2 | IPR008340 | |
| Domain | IGc2 | 7.34e-06 | 235 | 38 | 6 | SM00408 | |
| Domain | Ig_sub2 | 7.34e-06 | 235 | 38 | 6 | IPR003598 | |
| Domain | - | 4.60e-05 | 663 | 38 | 8 | 2.60.40.10 | |
| Domain | Ig-like_fold | 7.16e-05 | 706 | 38 | 8 | IPR013783 | |
| Domain | PDZ | 1.88e-04 | 141 | 38 | 4 | PF00595 | |
| Domain | IG | 1.90e-04 | 421 | 38 | 6 | SM00409 | |
| Domain | Ig_sub | 1.90e-04 | 421 | 38 | 6 | IPR003599 | |
| Domain | PDZ | 2.27e-04 | 148 | 38 | 4 | SM00228 | |
| Domain | PDZ | 2.45e-04 | 151 | 38 | 4 | PS50106 | |
| Domain | PDZ | 2.51e-04 | 152 | 38 | 4 | IPR001478 | |
| Domain | IG_LIKE | 4.32e-04 | 491 | 38 | 6 | PS50835 | |
| Domain | Ig-like_dom | 4.91e-04 | 503 | 38 | 6 | IPR007110 | |
| Domain | WHTH_DNA-bd_dom | 1.44e-03 | 242 | 38 | 4 | IPR011991 | |
| Domain | - | 3.49e-03 | 150 | 38 | 3 | 2.30.42.10 | |
| Domain | HEAT | 4.29e-03 | 48 | 38 | 2 | PF02985 | |
| Domain | Ubiquitin-rel_dom | 6.16e-03 | 184 | 38 | 3 | IPR029071 | |
| Domain | HEAT | 6.20e-03 | 58 | 38 | 2 | IPR000357 | |
| Domain | HEAT_REPEAT | 8.92e-03 | 70 | 38 | 2 | PS50077 | |
| Domain | - | 9.80e-03 | 218 | 38 | 3 | 1.10.10.10 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS | 1.06e-07 | 5 | 32 | 3 | M27447 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 2.11e-07 | 194 | 32 | 7 | M16312 | |
| Pathway | REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL | 5.90e-07 | 8 | 32 | 3 | M27100 | |
| Pathway | REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL | 8.84e-07 | 9 | 32 | 3 | MM14792 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.28e-06 | 158 | 32 | 6 | MM14812 | |
| Pathway | REACTOME_KILLING_MECHANISMS | 2.31e-06 | 12 | 32 | 3 | M29844 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 2.67e-06 | 99 | 32 | 5 | MM14624 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY | 5.83e-06 | 16 | 32 | 3 | M47823 | |
| Pathway | PID_BETA_CATENIN_DEG_PATHWAY | 8.47e-06 | 18 | 32 | 3 | M31 | |
| Pathway | PID_WNT_CANONICAL_PATHWAY | 1.18e-05 | 20 | 32 | 3 | M90 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 4.57e-05 | 31 | 32 | 3 | M27400 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 4.57e-05 | 31 | 32 | 3 | MM15154 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 5.04e-05 | 32 | 32 | 3 | M23 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 6.01e-05 | 188 | 32 | 5 | MM15828 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 7.21e-05 | 36 | 32 | 3 | M39699 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 7.83e-05 | 37 | 32 | 3 | M47411 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.32e-04 | 44 | 32 | 3 | MM15878 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 1.41e-04 | 45 | 32 | 3 | M47412 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.41e-04 | 45 | 32 | 3 | M39571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 1.51e-04 | 46 | 32 | 3 | M47409 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.51e-04 | 46 | 32 | 3 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.61e-04 | 47 | 32 | 3 | M7946 | |
| Pathway | WP_WNT_SIGNALING_WP363 | 2.05e-04 | 51 | 32 | 3 | M39721 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 2.57e-04 | 55 | 32 | 3 | M17807 | |
| Pathway | REACTOME_DEGRADATION_OF_DVL | 2.57e-04 | 55 | 32 | 3 | MM15153 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.65e-04 | 258 | 32 | 5 | MM14572 | |
| Pathway | REACTOME_DEGRADATION_OF_DVL | 2.86e-04 | 57 | 32 | 3 | M27399 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 3.17e-04 | 146 | 32 | 4 | M27288 | |
| Pathway | WP_WNT_SIGNALING | 3.50e-04 | 61 | 32 | 3 | MM15893 | |
| Pathway | REACTOME_HEMOSTASIS | 6.83e-04 | 679 | 32 | 7 | M8395 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 8.94e-04 | 511 | 32 | 6 | MM15330 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 9.25e-04 | 85 | 32 | 3 | MM15041 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 9.25e-04 | 85 | 32 | 3 | M48315 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 1.06e-03 | 89 | 32 | 3 | M39563 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 1.16e-03 | 92 | 32 | 3 | M27322 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.36e-03 | 97 | 32 | 3 | MM15926 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 1.40e-03 | 98 | 32 | 3 | M39731 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.52e-03 | 101 | 32 | 3 | M39448 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 1.52e-03 | 101 | 32 | 3 | MM15829 | |
| Pathway | KEGG_MELANOGENESIS | 1.52e-03 | 101 | 32 | 3 | M7761 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 1.52e-03 | 101 | 32 | 3 | M39387 | |
| Pathway | REACTOME_HEMOSTASIS | 1.58e-03 | 571 | 32 | 6 | MM14472 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 1.94e-03 | 110 | 32 | 3 | M39492 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 1.94e-03 | 110 | 32 | 3 | MM15977 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 2.10e-03 | 113 | 32 | 3 | M39669 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 2.26e-03 | 116 | 32 | 3 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 2.32e-03 | 117 | 32 | 3 | M39530 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 2.67e-03 | 123 | 32 | 3 | MM14988 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 3.85e-03 | 140 | 32 | 3 | M27550 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 3.87e-03 | 41 | 32 | 2 | M29748 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 3.93e-03 | 141 | 32 | 3 | MM15266 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 4.76e-03 | 151 | 32 | 3 | M19428 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 5.03e-03 | 154 | 32 | 3 | M39739 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 5.40e-03 | 158 | 32 | 3 | MM14791 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 6.04e-03 | 995 | 32 | 7 | MM14661 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 6.32e-03 | 330 | 32 | 4 | M7847 | |
| Pubmed | 1.21e-12 | 4 | 38 | 4 | 8817329 | ||
| Pubmed | Human dishevelled genes constitute a DHR-containing multigene family. | 1.21e-12 | 4 | 38 | 4 | 9192851 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 26219866 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.51e-12 | 13 | 38 | 5 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.51e-12 | 13 | 38 | 5 | 1985902 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 15207636 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 7628460 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 19285068 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 25724769 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 18003729 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 21760897 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 26284027 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 2133556 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 32521208 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 26374765 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 1719235 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.51e-12 | 13 | 38 | 5 | 33352461 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 19406938 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 10964771 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 38381498 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 32169849 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 20739537 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.51e-12 | 13 | 38 | 5 | 19273835 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 19621080 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.51e-12 | 13 | 38 | 5 | 25972571 | |
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.51e-12 | 13 | 38 | 5 | 29967450 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.51e-12 | 13 | 38 | 5 | 16638824 | |
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.51e-12 | 13 | 38 | 5 | 1326665 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 20044046 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 1633107 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 32150576 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 21081647 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.51e-12 | 13 | 38 | 5 | 39168268 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 22469976 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 11483763 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.51e-12 | 13 | 38 | 5 | 19358828 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.51e-12 | 13 | 38 | 5 | 21532628 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.51e-12 | 13 | 38 | 5 | 27695943 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.51e-12 | 13 | 38 | 5 | 28035001 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.51e-12 | 13 | 38 | 5 | 12832451 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.51e-12 | 13 | 38 | 5 | 15316023 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 8402684 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 20404914 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.51e-12 | 13 | 38 | 5 | 22092845 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 16680193 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.51e-12 | 13 | 38 | 5 | 21670291 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 22162753 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 11801635 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 2164599 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 26911181 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 1653760 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.51e-12 | 13 | 38 | 5 | 23935487 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 2702644 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 28913658 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 16619040 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.51e-12 | 13 | 38 | 5 | 32027621 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 19008452 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 8380065 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 18544705 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 1279194 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.51e-12 | 13 | 38 | 5 | 27777319 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 15331748 | ||
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 29377208 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.51e-12 | 13 | 38 | 5 | 15220458 | |
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.51e-12 | 13 | 38 | 5 | 8209741 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.51e-12 | 13 | 38 | 5 | 22406619 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 18848945 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.51e-12 | 13 | 38 | 5 | 8500759 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.51e-12 | 13 | 38 | 5 | 21949477 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.51e-12 | 13 | 38 | 5 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.51e-12 | 13 | 38 | 5 | 23800882 | |
| Pubmed | 1.51e-12 | 13 | 38 | 5 | 29396368 | ||
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 37531413 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 2.35e-12 | 14 | 38 | 5 | 18794798 | |
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 23780386 | ||
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 28567513 | ||
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 31083261 | ||
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 8207827 | ||
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 23469261 | ||
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 18454175 | ||
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 1648219 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 2.35e-12 | 14 | 38 | 5 | 26196244 | |
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 10491101 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 2.35e-12 | 14 | 38 | 5 | 17081782 | |
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 2.35e-12 | 14 | 38 | 5 | 34666041 | |
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 8896983 | ||
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 19700760 | ||
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 22159884 | ||
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 34619794 | ||
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 29907459 | ||
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 2.35e-12 | 14 | 38 | 5 | 32209360 | |
| Pubmed | 2.35e-12 | 14 | 38 | 5 | 22962327 | ||
| Interaction | PSG1 interactions | 4.00e-08 | 51 | 38 | 5 | int:PSG1 | |
| Interaction | PSG4 interactions | 3.44e-07 | 8 | 38 | 3 | int:PSG4 | |
| Interaction | PSG3 interactions | 9.29e-06 | 22 | 38 | 3 | int:PSG3 | |
| Interaction | PSG9 interactions | 9.29e-06 | 22 | 38 | 3 | int:PSG9 | |
| Interaction | PSG6 interactions | 2.07e-05 | 4 | 38 | 2 | int:PSG6 | |
| Interaction | DVL1P1 interactions | 3.45e-05 | 5 | 38 | 2 | int:DVL1P1 | |
| Interaction | NXN interactions | 4.99e-05 | 38 | 38 | 3 | int:NXN | |
| Interaction | RASSF9 interactions | 5.39e-05 | 39 | 38 | 3 | int:RASSF9 | |
| Interaction | CEACAM7 interactions | 7.23e-05 | 7 | 38 | 2 | int:CEACAM7 | |
| Interaction | CELSR3 interactions | 8.88e-05 | 46 | 38 | 3 | int:CELSR3 | |
| Interaction | CEP135 interactions | 1.51e-04 | 272 | 38 | 5 | int:CEP135 | |
| Interaction | MEGF8 interactions | 1.60e-04 | 56 | 38 | 3 | int:MEGF8 | |
| Interaction | DVL1 interactions | 1.83e-04 | 151 | 38 | 4 | int:DVL1 | |
| Interaction | RASSF10 interactions | 2.17e-04 | 62 | 38 | 3 | int:RASSF10 | |
| Interaction | PPM1A interactions | 2.46e-04 | 163 | 38 | 4 | int:PPM1A | |
| Interaction | RCOR1 interactions | 2.98e-04 | 494 | 38 | 6 | int:RCOR1 | |
| Cytoband | 19q13.2 | 4.76e-09 | 164 | 38 | 6 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 4.88e-05 | 1192 | 38 | 7 | chr19q13 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 4.50e-15 | 11 | 29 | 6 | 1315 | |
| GeneFamily | Dishevelled segment polarity proteins|PDZ domain containing | 1.48e-08 | 4 | 29 | 3 | 505 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 5.58e-06 | 163 | 29 | 5 | 590 | |
| GeneFamily | PDZ domain containing | 1.81e-03 | 152 | 29 | 3 | 1220 | |
| GeneFamily | Olfactory receptors, family 51 | 2.25e-03 | 44 | 29 | 2 | 164 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 7.17e-10 | 32 | 36 | 5 | MM2 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 8.14e-10 | 75 | 36 | 6 | MM605 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.15e-09 | 35 | 36 | 5 | MM757 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 3.03e-09 | 93 | 36 | 6 | M40279 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 6.00e-09 | 48 | 36 | 5 | MM531 | |
| Coexpression | DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS | 1.17e-07 | 171 | 36 | 6 | M40134 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 1.25e-07 | 87 | 36 | 5 | MM851 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.69e-07 | 182 | 36 | 6 | MM993 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 2.77e-07 | 102 | 36 | 5 | M10290 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 5.73e-07 | 224 | 36 | 6 | M40145 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | 8.21e-07 | 568 | 36 | 8 | MM3824 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 8.57e-07 | 128 | 36 | 5 | MM1000 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 1.12e-06 | 135 | 36 | 5 | MM965 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 1.48e-06 | 143 | 36 | 5 | MM989 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | 1.85e-06 | 436 | 36 | 7 | MM1326 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 2.50e-06 | 159 | 36 | 5 | MM760 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | 5.90e-06 | 741 | 36 | 8 | MM1037 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 7.84e-06 | 201 | 36 | 5 | MM1294 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 7.84e-06 | 201 | 36 | 5 | MM1006 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 1.19e-05 | 219 | 36 | 5 | MM3826 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 1.50e-05 | 230 | 36 | 5 | MM986 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | 3.61e-05 | 689 | 36 | 7 | MM1041 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | 3.78e-05 | 694 | 36 | 7 | MM1039 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 4.13e-05 | 284 | 36 | 5 | MM987 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 5.53e-05 | 302 | 36 | 5 | MM16604 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | 8.05e-05 | 534 | 36 | 6 | MM1050 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 1.10e-04 | 822 | 36 | 7 | M6782 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 1.40e-04 | 193 | 36 | 4 | M39321 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP | 1.48e-04 | 196 | 36 | 4 | M8858 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP | 1.51e-04 | 197 | 36 | 4 | M9969 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | 1.57e-04 | 871 | 36 | 7 | MM1005 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN | 1.60e-04 | 200 | 36 | 4 | M4624 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.60e-04 | 200 | 36 | 4 | M9188 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | 4.04e-04 | 463 | 36 | 5 | MM1011 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 5.23e-04 | 490 | 36 | 5 | MM1001 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 6.30e-04 | 27 | 36 | 2 | M1391 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 6.30e-04 | 27 | 36 | 2 | MM1135 | |
| CoexpressionAtlas | placenta | 2.05e-05 | 349 | 35 | 6 | placenta | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.09e-07 | 136 | 38 | 5 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 5.86e-07 | 191 | 38 | 5 | b5328733da3d3d77c4f6fc5e2ba2035f8898f172 | |
| Computational | Neighborhood of EGFR | 1.30e-08 | 32 | 27 | 5 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 2.08e-08 | 35 | 27 | 5 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 5.40e-08 | 42 | 27 | 5 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 8.64e-08 | 46 | 27 | 5 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 1.20e-07 | 49 | 27 | 5 | GNF2_KISS1 | |
| Computational | Neighborhood of CDKN1C | 5.33e-07 | 27 | 27 | 4 | GNF2_CDKN1C | |
| Computational | Genes in the cancer module 424. | 9.07e-04 | 18 | 27 | 2 | MODULE_424 | |
| Drug | AC1L1IPV | 7.02e-11 | 43 | 37 | 6 | CID000004683 | |
| Drug | Rgd Peptide | 1.01e-07 | 239 | 37 | 7 | CID000104802 | |
| Drug | pP-8 | 4.70e-07 | 10 | 37 | 3 | CID000444681 | |
| Disease | cD177 antigen measurement | 1.71e-11 | 18 | 36 | 5 | EFO_0021866 | |
| Disease | Robinow Syndrome | 8.67e-06 | 4 | 36 | 2 | C0265205 | |
| Disease | Robinow Syndrome, Autosomal Dominant | 8.67e-06 | 4 | 36 | 2 | C4551476 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 1.44e-05 | 5 | 36 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.92e-05 | 145 | 36 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 1.85e-03 | 52 | 36 | 2 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | visual perception measurement | 2.53e-03 | 223 | 36 | 3 | EFO_0009700 | |
| Disease | nicotine dependence | 4.10e-03 | 78 | 36 | 2 | EFO_0003768 | |
| Disease | basophil percentage of granulocytes | 4.63e-03 | 83 | 36 | 2 | EFO_0007995 | |
| Disease | Drug toxicity | 4.74e-03 | 84 | 36 | 2 | C0013221 | |
| Disease | Adverse reaction to drug | 4.74e-03 | 84 | 36 | 2 | C0041755 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NLLLPKLPTLPKNYS | 136 | Q9UJX5 | |
| RKLGVPLLPLTPAIY | 161 | Q4G176 | |
| LQLIIVILPGKTPVY | 516 | Q9H9G7 | |
| PYLVKLPLPAERVTL | 16 | Q92997 | |
| VLIILFPPLLIPTSK | 21 | P00846 | |
| DLLYVPPPLKVNLVV | 291 | Q9P1Y5 | |
| PYLVKIPVPAERITL | 26 | O14641 | |
| LPTLIYIVLKGNPPR | 316 | Q9UJ41 | |
| IPRPIKINLLFPIIY | 416 | Q9UHI5 | |
| PYLLPFISKLPQSIT | 361 | O94822 | |
| PLPLKYIRPILQQVA | 286 | Q86Z02 | |
| LTRLPTPVLLPYKPQ | 981 | Q96T76 | |
| TPVLLPYKPQVIRAL | 986 | Q96T76 | |
| TTLLPPIKVLVVYPS | 326 | Q9NRM6 | |
| LLPPVINPIIYGAKT | 281 | Q9H255 | |
| LIPPVLNPIIYSVKI | 296 | Q8NH61 | |
| VLPYLVPKLTTPPVN | 2076 | Q92616 | |
| IKLYKPLILPVTQAP | 211 | Q15070 | |
| MLLSYIRLPLLPPQL | 366 | Q9C0H6 | |
| VPLSPYLSPTVLLLV | 21 | Q9H6D8 | |
| PYTPPTLKLRNILDL | 741 | P51795 | |
| PYQVSLPPLTIQLPK | 56 | Q14314 | |
| PYLVKLPVAPERVTL | 16 | O14640 | |
| PYLVKLPVAPERVTL | 16 | P54792 | |
| TVLTVRPPLLPYIVN | 651 | Q8NC60 | |
| VTLNLLPKLPKPYIT | 231 | P11464 | |
| LLLPPTLNPIVYGVK | 291 | Q8NH56 | |
| VTLNLLPKLPKPYIT | 231 | Q16557 | |
| ELPTPLITQPLYKVV | 481 | Q6ZW31 | |
| PVSLQLLPLSLYPKP | 616 | A2VDJ0 | |
| TLNLLPKLPMPYITI | 231 | Q00889 | |
| SLNPATIYPVLPKLL | 556 | Q9Y289 | |
| TIYPVLPKLLSLLPL | 561 | Q9Y289 | |
| PLLYLLPVLTVLQTG | 466 | Q587J7 | |
| FTLNLLPKLPKPYIT | 231 | Q9UQ74 | |
| VTLNLLPKLPIPYIT | 231 | Q00887 | |
| SLFPLKVLPLTTPLV | 951 | Q15714 | |
| VTLNLLPKLPKPYIT | 231 | Q13046 | |
| LILILLEPIPQYSIP | 726 | Q15399 | |
| PAQLYTLQPKLPITV | 216 | P31939 | |
| TVPAYVPRKLIPITI | 231 | Q7Z7G0 |